Aardvark Therapeutics, Inc.Aardvark Therapeutics, Inc.Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc.

No trades
See on Supercharts

Price target

31.500.000.00%
The 4 analysts offering 1 year price forecasts for AARD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to AARD in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AARD EPS for the last quarter is −0.25 USD despite the estimation of −0.41 USD. In the next quarter EPS is expected to reach −0.67 USD. Track more of Aardvark Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Aardvark Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Aardvark Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, AARD price target is 31.50 USD with a max estimate of 50.00 USD and a min estimate of 21.00 USD. Check if this forecast comes true in a year, meanwhile watch Aardvark Therapeutics, Inc. stock price chart and keep track of the current situation with AARD news and stock market news.